Cargando…

Synergistic Effect of Metformin and Lansoprazole Against Gastric Cancer through Growth Inhibition

Cancer has been linked to metabolic disorders and diverse gene mutations. Metformin, which is widely used to treat type 2 diabetes, inhibits the growth of cancer cells in animal models. Here we investigated the effects of metformin on human gastric cancer cell lines. We also investigated the synergi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kao, Hsiao-Wei, Tsai, Kuo-Wang, Lin, Wen-chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198141/ https://www.ncbi.nlm.nih.gov/pubmed/37213670 http://dx.doi.org/10.7150/ijms.82407

Ejemplares similares

Synergistic Enhancement of Paclitaxel-induced Inhibition of Cell Growth by Metformin in Melanoma Cells
por: Ko, Gihyun, et al.
Publicado: (2019)

Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators
por: Cheng, Gang, et al.
Publicado: (2019)

Application of nanoparticles for oral delivery of acid-labile lansoprazole in the treatment of gastric ulcer: in vitro and in vivo evaluations
por: Alai, Milind, et al.
Publicado: (2015)

Dichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells
por: Li, Bo, et al.
Publicado: (2016)

Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo
por: Yu, Zhiyun, et al.
Publicado: (2015)

Repositioning of Lansoprazole as a Protective Agent Against Cisplatin-Induced Ototoxicity
por: Wakai, Eri, et al.
Publicado: (2022)

Immune and Inflammatory Responses in GERD and Lansoprazole
por: Isomoto, Hajime, et al.
Publicado: (2007)

Toxic epidermal necrolysis induced by lansoprazole()
por: Fracaroli, Tainá Scalfoni, et al.
Publicado: (2013)

Lansoprazole-Induced Improvement of Esophageal Submucosal Injury
por: Mine, Shinichiro, et al.
Publicado: (2007)

The Expression of Heme Oxygenase-1 Induced by Lansoprazole
por: Takagi, Tomohisa, et al.
Publicado: (2009)

Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells
por: Chang, Chia-Hsin, et al.
Publicado: (2017)

Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study
por: Chung, Ming-Hsuan, et al.
Publicado: (2022)

Metformin Treatment Suppresses Melanoma Cell Growth and Motility through Modulation of microRNA Expression
por: Tseng, Hui-Wen, et al.
Publicado: (2019)

Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2016)

Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer
por: Vujic, Igor, et al.
Publicado: (2014)

Vonoprazan 20 mg vs lansoprazole 30 mg for endoscopic submucosal dissection-induced gastric ulcers
por: Takahashi, Kazuya, et al.
Publicado: (2016)

Toxic epidermal necrolysis induced by Lansoprazole: Pharmacologic considerations*
por: Gomes, Ciro Martins
Publicado: (2013)

Lansoprazole is an antituberculous prodrug targeting cytochrome bc(1)
por: Rybniker, Jan, et al.
Publicado: (2015)

Ingestibility and Formulation Quality of Lansoprazole Orally Disintegrating Tablets
por: Chono, Sumio, et al.
Publicado: (2016)

Lansoprazole as an uncommon cause of anaphylaxis: What to give next?
por: Aydin, Ali Attila, et al.
Publicado: (2018)

Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway
por: Yamagishi, Naoko, et al.
Publicado: (2023)

Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway
por: Tsai, Hsin-Hwa, et al.
Publicado: (2017)

Urine miR-21-5p as a potential non-invasive biomarker for gastric cancer
por: Kao, Hsiao-Wei, et al.
Publicado: (2017)

Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo
por: Mussin, Nadiar, et al.
Publicado: (2017)

Synergistic effects of metformin with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathway
por: Ke, Jing, et al.
Publicado: (2017)

Randomised clinical trial: tegoprazan, a novel potassium‐competitive acid blocker, or lansoprazole in the treatment of gastric ulcer
por: Cho, Yu Kyung, et al.
Publicado: (2020)

Simultaneous Spectrophotometric Determination of Lansoprazole and Domperidone in Capsule Dosage Form
por: Sherje, A. P., et al.
Publicado: (2008)

The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production
por: Badiola, Nahuai, et al.
Publicado: (2013)

Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models
por: Li, Ying, et al.
Publicado: (2017)

Metformin prevents peritendinous fibrosis by inhibiting transforming growth factor-β signaling
por: Zheng, Wei, et al.
Publicado: (2017)

Lansoprazole inhibits mitochondrial superoxide production and cellular lipid peroxidation induced by indomethacin in RGM1 cells
por: Rai, Kanho, et al.
Publicado: (2011)

Cyclooxygenase-2 mediated synergistic effect of ursolic acid in combination with paclitaxel against human gastric carcinoma
por: Xu, Xian, et al.
Publicado: (2017)

Novel combination of celecoxib and metformin improves the antitumor effect by inhibiting the growth of Hepatocellular Carcinoma
por: Hu, Jun-Wen, et al.
Publicado: (2020)

Pharmacodynamics and Pharmacokinetics of a New Type of Compound Lansoprazole Capsule in Gastric Ulcer Rats and Beagle Dogs: Importance of Adjusting Oxidative Stress and Inflammation
por: Wei, Binbin, et al.
Publicado: (2019)

Long-Term Efficacy of Lansoprazole in Preventing Relapse of Erosive Reflux Esophagitis
por: Kovacs, Thomas O., et al.
Publicado: (2009)

Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole
por: Ashida, Kiyoshi, et al.
Publicado: (2018)

A Case of Lansoprazole-Induced Bullous Pemphigoid After Zantac Recall
por: Tran, Minh, et al.
Publicado: (2021)

Efficacy of soluble lansoprazole-impregnated beta-tricalcium phosphate for bone regeneration
por: Mishima, Kenichi, et al.
Publicado: (2022)

Novel Peritoneal Sclerosis Rat Model Developed by Administration of Bleomycin and Lansoprazole
por: Kunitatsu, Kosei, et al.
Publicado: (2023)

Geridonin and paclitaxel act synergistically to inhibit the proliferation of gastric cancer cells through ROS-mediated regulation of the PTEN/PI3K/Akt pathway
por: Wang, Sai-Qi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tk5ceiajeig93okfjil0u2sl90